PDT Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-197,049
| Closed | -$506K | – | 849 |
|
|
2024
Q2 | $506K | Buy |
+197,049
| New | +$506K | 0.05% | 462 |
|
|
2022
Q4 | – | Sell |
-45,800
| Closed | -$1.24M | – | 935 |
|
|
2022
Q3 | $1.24M | Sell |
45,800
-64,890
| -59% | -$1.75M | 0.19% | 161 |
|
|
2022
Q2 | $1.53M | Buy |
+110,690
| New | +$1.53M | 0.13% | 243 |
|
|
2015
Q3 | – | Sell |
-18,718
| Closed | -$599K | – | 1623 |
|
|
2015
Q2 | $599K | Buy |
+18,718
| New | +$599K | 0.02% | 913 |
|
|
2014
Q4 | – | Sell |
-42,070
| Closed | -$813K | – | 1148 |
|
|
2014
Q3 | $813K | Buy |
42,070
+6,266
| +18% | +$121K | 0.02% | 771 |
|
|
2014
Q2 | $1.22M | Buy |
+35,804
| New | +$1.22M | 0.03% | 631 |
|